Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: Correlation with invasive potential
- 1 August 1994
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 160 (2) , 275-286
- https://doi.org/10.1002/jcp.1041600209
Abstract
In the present study, we examined a panel of human breast cancer cell lines with regard to their expression of CD44 and ability to bind and degrade hyaluronan. The cell lines expressed varying amounts of different molecular weight forms of CD44 (85–200 kDa) and, in general, those that expressed the greatest amounts of CD44 were the most invasive as judged by in vitro assays. In addition, the ability to bind and degrade hyaluronan was restricted to the cell lines expressing high levels of CD44, and both these functions were blocked by an antibody to CD44 (Hermes-1). Moreover, the rate of [3H]hyaluronan degradation was highly correlated with the amount of CD44 (r = 0.951, P < 0.0001), as well as with the invasive potential of the cells. Scatchard analysis of the [3H]hyaluronan binding of these cells revealed the existence of significant differences in both their binding capacity and their dissociation constant. To determine the source of this deviation, the different molecular weight forms of CD44 were partially separated by gel filtration chromatography. In all cell lines, the 85 kDa form was able to bind hyaluronan, although with different affinities. In contrast, not all of the high molecular weight forms of CD44 had this ability. These results illustrate the diversity of CD44 molecules in invasive tumor cells, and suggest that one of their major functions is to degrade hyaluronan.Keywords
This publication has 31 references indexed in Scilit:
- Lounging in a lysosome: the intracellular lifestyle of Coxiella burnetiiCellular Microbiology, 2007
- Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition.The Journal of cell biology, 1992
- Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell linesJournal of Cellular Physiology, 1992
- The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan.The Journal of cell biology, 1992
- Hyaluronan can be non-enzymatically linked to protein through an alkali sensitive bondConnective Tissue Research, 1992
- Distinct effects of two CD44 isoforms on tumor growth in vivo.The Journal of Experimental Medicine, 1991
- CD44 is the principal cell surface receptor for hyaluronateCell, 1990
- The cell surface hyaluronate binding sites of invasive human bladder carcinoma cellsBiochemical and Biophysical Research Communications, 1987
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- CYTOCHEMICAL DEMONSTRATION OF PEROXIDASE ACTIVITY WITH 3-AMINO-9-ETHYLCARBAZOLEJournal of Histochemistry & Cytochemistry, 1965